These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Real-world utilization of methotrexate or prednisone co-therapy with etanercept among Canadian patients with rheumatoid arthritis: a retrospective cohort study. Khraishi M, Ivanovic J, Zhang Y, Millson B, Brabant MJ, Woolcott J, Jones H, Curiale C. Curr Med Res Opin; 2019 Nov; 35(11):2025-2033. PubMed ID: 31237785 [Abstract] [Full Text] [Related]
5. Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept. Verazza S, Davì S, Consolaro A, Bovis F, Insalaco A, Magni-Manzoni S, Nicolai R, Marafon DP, De Benedetti F, Gerloni V, Pontikaki I, Rovelli F, Cimaz R, Marino A, Zulian F, Martini G, Pastore S, Sandrin C, Corona F, Torcoletti M, Conti G, Fede C, Barone P, Cattalini M, Cortis E, Breda L, Olivieri AN, Civino A, Podda R, Rigante D, La Torre F, D'Angelo G, Jorini M, Gallizzi R, Maggio MC, Consolini R, De Fanti A, Muratore V, Alpigiani MG, Ruperto N, Martini A, Ravelli A, Italian Pediatric Rheumatology Study Group. Pediatr Rheumatol Online J; 2016 Dec 20; 14(1):68. PubMed ID: 27993144 [Abstract] [Full Text] [Related]
7. The Canadian methotrexate and etanercept outcome study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis. Pope JE, Haraoui B, Thorne JC, Vieira A, Poulin-Costello M, Keystone EC. Ann Rheum Dis; 2014 Dec 20; 73(12):2144-51. PubMed ID: 23979914 [Abstract] [Full Text] [Related]
9. Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritis. Bader-Meunier B, Krzysiek R, Lemelle I, Pajot C, Carbasse A, Poignant S, Melki I, Quartier P, Choupeaux L, Henry E, Treluyer JM, Belot A, Hacein-Bey-Abina S, Urien S. Semin Arthritis Rheum; 2019 Jun 20; 48(6):1014-1018. PubMed ID: 30396593 [Abstract] [Full Text] [Related]
13. Etanercept is effective as monotherapy or in combination with methotrexate in rheumatoid arthritis: subanalysis of an observational study. Gaubitz M, Göttl KH, Behmer O, Lippe R, Meng T, Löschmann PA. Clin Rheumatol; 2017 Sep 20; 36(9):1989-1996. PubMed ID: 28756532 [Abstract] [Full Text] [Related]
14. Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial. Emery P, Horton S, Dumitru RB, Naraghi K, van der Heijde D, Wakefield RJ, Hensor EMA, Buch MH. Ann Rheum Dis; 2020 Apr 20; 79(4):464-471. PubMed ID: 31996367 [Abstract] [Full Text] [Related]
20. Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial. Kameda H, Ueki Y, Saito K, Nagaoka S, Hidaka T, Atsumi T, Tsukano M, Kasama T, Shiozawa S, Tanaka Y, Takeuchi T, Japan Biological Agent Study Integrated Consortium. Mod Rheumatol; 2010 Dec 20; 20(6):531-8. PubMed ID: 20574649 [Abstract] [Full Text] [Related] Page: [Next] [New Search]